CLMT vs. DK, VTNR, BPT, CVI, DMLP, SPH, JKS, ACDC, NRP, and AMRC
Should you be buying Calumet Specialty Products Partners stock or one of its competitors? The main competitors of Calumet Specialty Products Partners include Delek US (DK), Vertex Energy (VTNR), BP Prudhoe Bay Royalty Trust (BPT), CVR Energy (CVI), Dorchester Minerals (DMLP), Suburban Propane Partners (SPH), JinkoSolar (JKS), ProFrac (ACDC), Natural Resource Partners (NRP), and Ameresco (AMRC).
Delek US (NYSE:DK) and Calumet Specialty Products Partners (NASDAQ:CLMT) are both small-cap oils/energy companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.
Delek US received 319 more outperform votes than Calumet Specialty Products Partners when rated by MarketBeat users. Likewise, 62.15% of users gave Delek US an outperform vote while only 50.16% of users gave Calumet Specialty Products Partners an outperform vote.
Delek US presently has a consensus price target of $28.89, suggesting a potential upside of 0.76%. Calumet Specialty Products Partners has a consensus price target of $21.00, suggesting a potential upside of 33.25%. Given Delek US's stronger consensus rating and higher possible upside, analysts clearly believe Calumet Specialty Products Partners is more favorable than Delek US.
Calumet Specialty Products Partners has a net margin of -0.10% compared to Calumet Specialty Products Partners' net margin of -0.48%. Calumet Specialty Products Partners' return on equity of 7.37% beat Delek US's return on equity.
97.0% of Delek US shares are owned by institutional investors. Comparatively, 34.4% of Calumet Specialty Products Partners shares are owned by institutional investors. 1.8% of Delek US shares are owned by company insiders. Comparatively, 2.9% of Calumet Specialty Products Partners shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Calumet Specialty Products Partners has lower revenue, but higher earnings than Delek US. Calumet Specialty Products Partners is trading at a lower price-to-earnings ratio than Delek US, indicating that it is currently the more affordable of the two stocks.
Delek US has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, Calumet Specialty Products Partners has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500.
In the previous week, Calumet Specialty Products Partners had 15 more articles in the media than Delek US. MarketBeat recorded 25 mentions for Calumet Specialty Products Partners and 10 mentions for Delek US. Calumet Specialty Products Partners' average media sentiment score of 0.40 beat Delek US's score of 0.21 indicating that Delek US is being referred to more favorably in the media.
Summary
Calumet Specialty Products Partners beats Delek US on 10 of the 18 factors compared between the two stocks.
Get Calumet Specialty Products Partners News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLMT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CLMT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Calumet Specialty Products Partners Competitors List
Related Companies and Tools
